NTRK2 and cancer: Recently, several studies have shown that BDNF and/or its receptor, tropo-myosin-related kinase B (TrkB), are involved in cancer growth and metastasis in several cancers, including neuroblastoma4, pancreatic ductal carcinoma5, prostate cancer6, hepatocellular carcinoma7, and lung cancer8.